evolcSign inStart free
Menu

Nanobiotix

Physics-based nanotherapeutics for cancer, with lead candidate NBTXR3 in clinical development with Janssen

Paris, FranceFounded 2003nanobiotix.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Nanobiotix

Nanobiotix is a late-stage clinical biotechnology company that discovers, develops, manufactures and commercializes physics-based nanotherapeutics. Its lead candidate, NBTXR3, is described as a potential first-in-class radioenhancer for solid tumors, designed to increase the radiation dose absorbed by tumor cells while sparing surrounding healthy tissue.

Nanobiotix is engaged in a global licensing agreement with Janssen Pharmaceutica NV, a Johnson & Johnson company, for the co-development and commercialization of NBTXR3. The initial development plan focuses on cancers of the head, neck and lungs. The company also lists a Curadigm Nanoprimer platform and collaborations with research institutions.

The company was founded in 2003 and is based in Paris, France. Its leadership team includes a CEO, CFO, CMO and other executives, and it has a scientific advisory board drawn from hospitals and cancer centers in France, the US, Switzerland and the UK. The website recruits for open positions.

Product: NBTXR3, a physics-based nanotherapeutic radioenhancer for solid tumors, developed under a licensing agreement with Janssen.

Jobs at Nanobiotix

No open positions listed right now.

Leadership

  • Laurent Levy · Chief Executive Officer
    Source: company website
  • Anne-Juliette Hermant · Chief People Officer
    Source: company website
  • Anne-Sophie Larivière · Chief Product Innovation & Delivery Officer
    Source: company website
  • Arnd Christ · Chief Financial Officer
    Source: company website
  • Brandon Owens · Vice President, Strategic Marketing and Corporate Communications
    Source: company website

More biotech & pharma companies

  • Naobios

    GMP contract development and manufacturing of viral vaccines, vectors and other virus-based products for biotech and pharmaceutical sponsors
    Saint-Herblain, FranceBiotech & pharmaFounded 20132 open jobs
    New on EvolcRemote-friendly

  • Naolys

    Plant cell biotechnology ingredients for cosmetics manufacturers
    Cestas, FranceBiotech & pharmaFounded 2003
    New on Evolc

  • Netris Pharma

    Oncology biopharma developing anti-Netrin-1 antibodies to overcome cancer treatment resistance, spun out of Centre Léon Bérard in Lyon
    Lyon, FranceBiotech & pharmaFounded 2008
    New on Evolc

  • Neuro-Sys

    Preclinical neuroscience research services for pharmaceutical, biotech and academic organizations developing CNS and PNS therapies
    Gardanne, FranceBiotech & pharmaFounded 20132 open jobs
    New on Evolc

  • NG Biotech

    Rapid in vitro diagnostic tests for healthcare professionals, patients and global partners
    Guipry-Messac, FranceBiotech & pharmaFounded 20122 open jobs
    New on Evolc

  • Noraker

    Develops and manufactures resorbable biomaterial implants for surgeons treating bone defects and supporting bone regeneration
    Lyon, FranceBiotech & pharmaFounded 2005
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Elementor
  • Google Analytics 4
  • Google reCAPTCHA
  • Matomo
  • Microsoft Clarity
  • WordPress
  • nginx